abeglutide glp-1 GLP-1s Q&A: How Specific GLP-1s Impact

Nausea affects up to 40% of GLP-1 users during initial treatment, but simple dietary and lifestyle adjustments can significantly reduce discomfort

Approved Medical Solutions Thermo Advanced Thermogenic & Metabolic Support

NRD per 1000 people 5.57 (6.61 to 4.53)), cannabis use (0.86 (0.81 to 0.90), NRD 2.25 (3.00 to 1.50)), cocaine use (0.80 (0.72 to 0.88), NRD 0.97 (1.37 to 0.57)), nicotine use (0.80 (0.74 to 0.87), NRD 1.64 (2.19 to 1.09)), and opioid use (0.75 (0.67 to 0.85), NRD 0.86 (1.19 to 0.52)), and other SUDs (0.87 (0.81 to 0.94), NRD 1.12 (1.68 to 0.55)) and composite outcome of all incident SUDs (0.86 (0.83 to 0.88), NRD 6.61 (7.95 to 5.26))

The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity

Personalized plans, expert guidance, and FDA-approved injections like Wegovy, Mounjaro, Contrave, Ozempic, and Qsymia.

Finding what looks like blood in your stool can be a result of something you ate